Hershey Trust Company’s Crinetics Pharmaceuticals CRNX Stock Holding History

Hershey Trust Company’s Portfolio CRNX Stock Details CRNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7,521	Closed	-$214K	–	33
2021 Q4	$214K	Buy	+7,521	New	+$185K	﹤0.01%	27
2021 Q3	–	Sell	-19,778	Closed	-$373K	–	34
2021 Q2	$373K	Hold	19,778	–	–	﹤0.01%	21
2021 Q1	$302K	Hold	19,778	–	–	﹤0.01%	22
2020 Q4	$279K	Hold	19,778	–	–	﹤0.01%	21
2020 Q3	$310K	Hold	19,778	–	–	﹤0.01%	13
2020 Q2	$347K	Buy	19,778 +16,883	+583%	+$288K	﹤0.01%	9
2020 Q1	$43K	Sell	2,895 -3,858	-57%	-$79.1K	﹤0.01%	26
2019 Q4	$169K	Hold	6,753	–	–	﹤0.01%	18
2019 Q3	$102K	Hold	6,753	–	–	﹤0.01%	18
2019 Q2	$169K	Sell	6,753 -4,194	-38%	-$104K	﹤0.01%	15
2019 Q1	$249K	Buy	+10,947	New	+$269K	﹤0.01%	15

Other funds holding CRNX

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Hershey Trust Company's CRNX Position: Q1 2022 in Review

Hershey Trust Company sold out of Crinetics Pharmaceuticals (CRNX) in Q1 2022, closing a stake of 7,521 shares — an estimated $214K sold.

Hershey Trust Company first reported a position in CRNX in Q1 2019 and held it in 11 quarters. The position peaked at $373K in Q2 2021. 116 funds tracked by Wall St. Rank hold CRNX as of Q1 2022.

Hershey Trust Company reported no remaining Crinetics Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
Hershey Trust Company sold 7,521 Crinetics Pharmaceuticals shares in Q1 2022, an estimated $214K.
Hershey Trust Company first reported a position in Crinetics Pharmaceuticals in Q1 2019 and held it in 11 quarters.
Hershey Trust Company's Crinetics Pharmaceuticals position peaked at $373K in Q2 2021.
116 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q1 2022.

Based on Hershey Trust Company's 13F filing for Q1 2022, filed 13 May 2022.